Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib
暂无分享,去创建一个
P. Erben | R. Hehlmann | A. Hochhaus | O. Ottmann | L. Wunderle | M. Dugan | T. Ernst | P. La Rosée | H. Konig | Y. Shou | Martin C Mueller | N. Härtel | A. Binckebanck | Susanne Holm-Eriksen | Julia Debatin | N. Härtel | M. Mueller